Last week saw significant volatility. However, positive sentiment intensified throughout the biotech space, propelled by favorable legislation and encouraging trial data. Shares of Recursion Pharmaceuticals (RXRX) traded down about 17% last Friday, participating in a broad market slump catalyzed by macroeconomic uncertainty. Shares of Recursion have increased 2.9% between September 16 and September 21, according [...] The post Positive Sentiment in Biotech Intensifies, Add ARKG appeared first on ETF Trends .